ACITRETIN

ACITRETIN was reported 4929 times

ACITRETIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACROKERATOSIS PARANEOPLASTICA 4 0.4444
1 NEUROLOGIC NEGLECT SYNDROME 198 0.3561
2 PHOTOTHERAPY 9 0.2727
3 CAROTID ARTERY THROMBOSIS 200 0.2356
4 DERMATOPATHIC LYMPHADENOPATHY 4 0.1667
5 SYNDESMOPHYTE 5 0.1562
6 BOTRYOMYCOSIS 6 0.1538
7 ADJUSTMENT DISORDER 194 0.1492
8 PITYRIASIS RUBRA PILARIS 32 0.1345
9 OTITIS EXTERNA FUNGAL 4 0.1176
10 ERYTHRODERMIC PSORIASIS 63 0.0765
11 PERSONALITY DISORDER 198 0.0755
12 DELUSION OF PARASITOSIS 10 0.0637
13 GENERALISED PUSTULAR PSORIASIS 18 0.0621
14 SCROTAL CYST 5 0.0588
15 GASTRITIS FUNGAL 6 0.0583
16 JOINT ANKYLOSIS 30 0.0528
17 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 21 0.0516
18 KERATOSIS FOLLICULAR 4 0.0513
19 DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS 4 0.0513
20 ISCHAEMIC SKIN ULCER 4 0.0430
21 INFECTED DERMAL CYST 15 0.0416
22 VULVAL DISORDER 26 0.0393
23 NEUROENDOCRINE TUMOUR OF THE LUNG 4 0.0370
24 PSORIASIS AREA SEVERITY INDEX INCREASED 6 0.0364
25 SELF-CONSCIOUSNESS 9 0.0354
26 GENITAL ULCERATION 26 0.0338
27 INTERTRIGO 18 0.0330
28 BONE CYST 30 0.0320
29 CUTANEOUS T-CELL LYMPHOMA 40 0.0317
30 VULVOVAGINAL ERYTHEMA 26 0.0311
31 BODY SURFACE AREA INCREASED 4 0.0310
32 GANGRENE 186 0.0308
33 NON-ALCOHOLIC FATTY LIVER 10 0.0297
34 PALMOPLANTAR PUSTULOSIS 15 0.0284
35 EXTRASKELETAL OSSIFICATION 6 0.0279
36 DACTYLITIS 27 0.0275
37 SENSORY LOSS 217 0.0269
38 ILEAL ULCER 26 0.0257
39 TRANSMISSION OF DRUG VIA SEMEN 12 0.0249
40 KERATOACANTHOMA 17 0.0249
41 WEANING FAILURE 9 0.0247
42 REBOUND PSORIASIS 14 0.0241
43 HEMIPLEGIA 197 0.0237
44 ARTERIAL OCCLUSIVE DISEASE 186 0.0236
45 HEMIANOPIA 22 0.0222
46 EMPYEMA 44 0.0221
47 ONYCHALGIA 22 0.0219
48 GROIN INFECTION 12 0.0218
49 ACANTHOSIS 7 0.0213
50 AFFECT LABILITY 201 0.0209
51 VULVOVAGINAL CANDIDIASIS 27 0.0200
52 POST INFLAMMATORY PIGMENTATION CHANGE 9 0.0199
53 PUSTULAR PSORIASIS 68 0.0198
54 MYCOSIS FUNGOIDES 16 0.0194
55 MOTOR DYSFUNCTION 198 0.0194
56 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 4 0.0192
57 LEPROSY 4 0.0192
58 SKIN HAEMORRHAGE 282 0.0190
59 STICKY SKIN 7 0.0175
60 GUTTATE PSORIASIS 14 0.0171
61 PREGNANCY OF PARTNER 12 0.0169
62 SINUS CONGESTION 223 0.0165
63 GRANULOMA ANNULARE 12 0.0163
64 MUSCLE SPASTICITY 200 0.0163
65 DEVICE RELATED SEPSIS 32 0.0159
66 RETROPERITONEAL ABSCESS 5 0.0158
67 SKIN PLAQUE 127 0.0150
68 PYOGENIC GRANULOMA 7 0.0150
69 LENTIGO MALIGNA 4 0.0149
70 ECTROPION 5 0.0148
71 OSTEOLYSIS 30 0.0147
72 BLOOD ALBUMIN INCREASED 13 0.0146
73 NAIL PSORIASIS 9 0.0146
74 COORDINATION ABNORMAL 200 0.0143
75 VULVOVAGINAL SWELLING 26 0.0142
76 ALANINE AMINOTRANSFERASE ABNORMAL 30 0.0142
77 DERMATITIS EXFOLIATIVE GENERALISED 48 0.0138
78 RESPIRATORY TRACT CONGESTION 217 0.0136
79 STASIS DERMATITIS 9 0.0132
80 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 30 0.0130
81 BLOOD IMMUNOGLOBULIN M DECREASED 13 0.0130
82 PAPILLOMA 4 0.0126
83 PARAKERATOSIS 4 0.0123
84 INDURATION 22 0.0123
85 XEROSIS 15 0.0121
86 METASTATIC SQUAMOUS CELL CARCINOMA 6 0.0117
87 CUTANEOUS SYMPTOM 8 0.0117
88 HEMIPARESIS 198 0.0117
89 HEPATIC FIBROSIS 39 0.0114
90 SINUS DISORDER 221 0.0111
91 HYPEREOSINOPHILIC SYNDROME 6 0.0111
92 DRUG EXPOSURE BEFORE PREGNANCY 11 0.0108
93 ACTINIC KERATOSIS 28 0.0108
94 SKIN INJURY 35 0.0105
95 CUSHING'S SYNDROME 7 0.0101
96 ABDOMINAL ABSCESS 44 0.0099
97 TONSIL CANCER 8 0.0099
98 SNEEZING 221 0.0098
99 ACOUSTIC NEUROMA 4 0.0098
100 DIFFUSE ALOPECIA 18 0.0097
101 SQUAMOUS CELL CARCINOMA OF SKIN 58 0.0096
102 ENTHESOPATHY 15 0.0096
103 CEREBRAL PALSY 9 0.0095
104 IMMUNOGLOBULINS DECREASED 13 0.0095
105 SKIN ATROPHY 54 0.0094
106 PRURITUS GENITAL 22 0.0093
107 EATING DISORDER 197 0.0092
108 MUSCULAR DYSTROPHY 4 0.0092
109 PSORIASIS 1191 0.0091
110 BONE EROSION 32 0.0090
111 HYDROTHORAX 7 0.0084
112 PALMOPLANTAR KERATODERMA 6 0.0083
113 DIFFERENTIATION SYNDROME 6 0.0082
114 ENTEROCOCCAL INFECTION 39 0.0081
115 SKIN EROSION 26 0.0081
116 STAPHYLOCOCCAL BACTERAEMIA 35 0.0080
117 SERUM SICKNESS-LIKE REACTION 5 0.0079
118 THROMBOTIC THROMBOCYTOPENIC PURPURA 28 0.0079
119 LIPIDS INCREASED 16 0.0079
120 MEAN CELL HAEMOGLOBIN INCREASED 13 0.0078
121 STAPHYLOCOCCAL SEPSIS 38 0.0077
122 TONGUE ULCERATION 26 0.0077
123 HIDRADENITIS 69 0.0076
124 HUMAN POLYOMAVIRUS INFECTION 4 0.0075
125 HYDROCELE 8 0.0075
126 POSTOPERATIVE ABSCESS 5 0.0075
127 ANGIOPLASTY 11 0.0074
128 DERMATITIS PSORIASIFORM 15 0.0073
129 LICHEN PLANUS 17 0.0073
130 KLEBSIELLA INFECTION 37 0.0073
131 VASCULAR DEVICE INFECTION 33 0.0073
132 SQUAMOUS CELL CARCINOMA 68 0.0072
133 MACULE 20 0.0072
134 ANGINA PECTORIS 205 0.0071
135 LIP HAEMORRHAGE 9 0.0071
136 PSORIATIC ARTHROPATHY 286 0.0070
137 DYSLIPIDAEMIA 35 0.0069
138 APHASIA 208 0.0069
139 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 4 0.0068
140 CYSTITIS 215 0.0067
141 VASOSPASM 6 0.0065
142 STEROID DIABETES 9 0.0060
143 LYMPHOCYTIC INFILTRATION 6 0.0060
144 INFECTIOUS MONONUCLEOSIS 13 0.0058
145 SERUM FERRITIN DECREASED 10 0.0058
146 ANAL HAEMORRHAGE 16 0.0057
147 UPPER AIRWAY OBSTRUCTION 5 0.0056
148 HYPERKERATOSIS 30 0.0054
149 DYSARTHRIA 203 0.0054
150 BLOOD IMMUNOGLOBULIN G DECREASED 13 0.0052
151 T-CELL LYMPHOMA 6 0.0052
152 RASH PUSTULAR 37 0.0051
153 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
154 SKIN SENSITISATION 5 0.0048
155 EAR CONGESTION 13 0.0048
156 PERITONSILLAR ABSCESS 4 0.0048
157 LATENT TUBERCULOSIS 10 0.0048
158 INCORRECT DOSAGE ADMINISTERED 23 0.0047
159 C-REACTIVE PROTEIN ABNORMAL 30 0.0047
160 ORCHITIS 5 0.0046
161 SKIN EXFOLIATION 375 0.0044
162 STENOTROPHOMONAS INFECTION 6 0.0044
163 EFFUSION 6 0.0044
164 BLOODY DISCHARGE 5 0.0044
165 INCREASED BRONCHIAL SECRETION 11 0.0043
166 INJECTION SITE ULCER 4 0.0042
167 GROIN ABSCESS 5 0.0042
168 PUSTULE 10 0.0042
169 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 30 0.0042
170 CHAPPED LIPS 18 0.0041
171 FAECAL CALPROTECTIN INCREASED 13 0.0041
172 CONCOMITANT DISEASE PROGRESSION 8 0.0041
173 PAIN OF SKIN 109 0.0040
174 RHINORRHOEA 261 0.0040
175 GASTROINTESTINAL TUBE INSERTION 10 0.0040
176 INTELLECTUAL DISABILITY 6 0.0039
177 TESTICULAR SWELLING 5 0.0039
178 GENITAL HERPES 6 0.0039
179 JOINT EFFUSION 27 0.0039
180 METASTASES TO PLEURA 4 0.0038
181 CREATININE RENAL CLEARANCE DECREASED 15 0.0037
182 GALLBLADDER ENLARGEMENT 4 0.0037
183 CANDIDA INFECTION 62 0.0037
184 POST PROCEDURAL SWELLING 4 0.0036
185 PLANTAR FASCIITIS 12 0.0036
186 LICHENOID KERATOSIS 8 0.0035
187 ORAL CANDIDIASIS 46 0.0035
188 GASTROINTESTINAL INFECTION 31 0.0035
189 SEBORRHOEIC KERATOSIS 5 0.0034
190 CATARACT 204 0.0034
191 ARTHRITIS 267 0.0034
192 CAPILLARY LEAK SYNDROME 7 0.0034
193 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
194 CHOLANGIOCARCINOMA 5 0.0034
195 REFLUX GASTRITIS 4 0.0033
196 SMALL CELL LUNG CANCER 5 0.0033
197 GINGIVAL HYPERTROPHY 5 0.0033
198 SKIN FRAGILITY 8 0.0033
199 RASH MORBILLIFORM 9 0.0032
200 SKIN PAPILLOMA 13 0.0032
201 NEOPLASM SKIN 5 0.0032
202 ONYCHOLYSIS 5 0.0032
203 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
204 TUBERCULIN TEST POSITIVE 8 0.0032
205 TOTAL LUNG CAPACITY DECREASED 5 0.0031
206 PAPULE 22 0.0031
207 HYPERCHOLESTEROLAEMIA 30 0.0031
208 ONYCHOMADESIS 13 0.0031
209 HYPERSENSITIVITY VASCULITIS 8 0.0030
210 LIVE BIRTH 25 0.0030
211 MUCOSAL DRYNESS 6 0.0030
212 SKIN INFECTION 33 0.0029
213 SCRATCH 31 0.0029
214 LAZINESS 5 0.0029
215 SKIN LESION 80 0.0029
216 STREPTOCOCCAL INFECTION 16 0.0029
217 INFLAMMATORY BOWEL DISEASE 28 0.0029
218 PSEUDOMONAL SEPSIS 5 0.0029
219 SKIN HYPERPIGMENTATION 24 0.0028
220 PARADOXICAL DRUG REACTION 10 0.0027
221 SYNOVITIS 49 0.0027
222 HYPERTRICHOSIS 5 0.0027
223 SKIN FISSURES 52 0.0027
224 DISTRIBUTIVE SHOCK 6 0.0026
225 INFECTED SKIN ULCER 5 0.0026
226 INFLUENZA LIKE ILLNESS 217 0.0026
227 MANTLE CELL LYMPHOMA 4 0.0026
228 BRAIN OEDEMA 33 0.0026
229 CYTOMEGALOVIRUS COLITIS 6 0.0026
230 PROTEIN URINE PRESENT 13 0.0026
231 DERMATITIS EXFOLIATIVE 13 0.0026
232 BUNDLE BRANCH BLOCK LEFT 11 0.0026
233 METHAEMOGLOBINAEMIA 6 0.0026
234 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 183 0.0026
235 VAGINAL DISCHARGE 26 0.0026
236 INFLUENZA 286 0.0026
237 BICYTOPENIA 5 0.0025
238 GASTROINTESTINAL DISORDER 227 0.0025
239 LOCALISED INFECTION 61 0.0025
240 TRANSAMINASES INCREASED 56 0.0025
241 BASAL CELL CARCINOMA 39 0.0025
242 HEPATIC CIRRHOSIS 46 0.0024
243 HAND DEFORMITY 32 0.0024
244 BODY TEMPERATURE DECREASED 24 0.0024
245 INTESTINAL POLYP 4 0.0024
246 TREATMENT FAILURE 201 0.0024
247 PAPILLOMA VIRAL INFECTION 4 0.0024
248 OTITIS MEDIA 8 0.0024
249 IGA NEPHROPATHY 4 0.0024
250 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 131 0.0024
251 LOCALISED OEDEMA 11 0.0024
252 THERAPY PARTIAL RESPONDER 37 0.0024
253 DYSPHAGIA 225 0.0024
254 SINUSITIS 241 0.0023
255 ONYCHOCLASIS 16 0.0023
256 LYMPHOCYTOSIS 5 0.0023
257 LIP DRY 21 0.0023
258 TENDERNESS 24 0.0023
259 INFECTION SUSCEPTIBILITY INCREASED 5 0.0023
260 NECROTISING FASCIITIS 8 0.0023
261 CONCOMITANT DISEASE AGGRAVATED 14 0.0023
262 HEPATIC STEATOSIS 42 0.0023
263 GLOSSITIS 8 0.0023
264 PEMPHIGOID 17 0.0023
265 SKIN DISORDER 75 0.0022
266 CHEILITIS 12 0.0022
267 GLUCOSE TOLERANCE IMPAIRED 13 0.0022
268 ARTHRITIS BACTERIAL 9 0.0022
269 SENSORY DISTURBANCE 35 0.0022
270 PNEUMONIA KLEBSIELLA 4 0.0022
271 CHEST DISCOMFORT 222 0.0022
272 BLOOD CHOLESTEROL ABNORMAL 10 0.0022
273 SECRETION DISCHARGE 27 0.0022
274 NEURODERMATITIS 8 0.0021
275 DECREASED IMMUNE RESPONSIVENESS 21 0.0021
276 ADENOCARCINOMA OF COLON 4 0.0021
277 FACE OEDEMA 36 0.0021
278 GAIT INABILITY 71 0.0021
279 THERMAL BURN 15 0.0021
280 PURULENT DISCHARGE 9 0.0021
281 BACTERAEMIA 25 0.0021
282 RED BLOOD CELL SEDIMENTATION RATE INCREASED 23 0.0021
283 MUSCULAR WEAKNESS 236 0.0021
284 HYPERTRIGLYCERIDAEMIA 12 0.0020
285 SEXUAL DYSFUNCTION 24 0.0020
286 LYMPHOPROLIFERATIVE DISORDER 6 0.0020
287 REBOUND EFFECT 23 0.0020
288 RHEUMATOID ARTHRITIS 230 0.0020
289 IDIOPATHIC PULMONARY FIBROSIS 8 0.0020
290 SCAB 23 0.0020
291 VITAMIN D DECREASED 17 0.0020
292 MYASTHENIA GRAVIS 16 0.0020
293 DEVICE RELATED INFECTION 30 0.0019
294 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
295 CACHEXIA 10 0.0019
296 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 16 0.0019
297 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 15 0.0019
298 SKIN TIGHTNESS 9 0.0019
299 THROMBOCYTOSIS 7 0.0019
300 POLYARTHRITIS 10 0.0019
301 DRUG-INDUCED LIVER INJURY 59 0.0019
302 CUSHINGOID 6 0.0019
303 SKIN DISCOMFORT 5 0.0019
304 PREGNANCY 37 0.0018
305 ANGINA UNSTABLE 12 0.0018
306 CERVICAL DYSPLASIA 4 0.0018
307 BLOOD PRESSURE INCREASED 277 0.0018
308 DERMATITIS ACNEIFORM 11 0.0018
309 THERAPEUTIC RESPONSE DELAYED 5 0.0018
310 CLOSTRIDIUM DIFFICILE INFECTION 39 0.0018
311 ADENOCARCINOMA 4 0.0018
312 METASTASES TO LYMPH NODES 12 0.0018
313 B-CELL LYMPHOMA 6 0.0018
314 HAEMATOLOGICAL MALIGNANCY 5 0.0018
315 CELLULITIS 88 0.0017
316 NASOPHARYNGITIS 318 0.0017
317 MOUTH ULCERATION 36 0.0017
318 NEGATIVE THOUGHTS 5 0.0017
319 STRIDOR 5 0.0017
320 INGROWING NAIL 4 0.0017
321 HERPES SIMPLEX 11 0.0017
322 SARCOIDOSIS 8 0.0017
323 ABSCESS LIMB 7 0.0016
324 STAPHYLOCOCCAL INFECTION 54 0.0016
325 RECTAL DISCHARGE 6 0.0016
326 INJECTION SITE INJURY 9 0.0016
327 PALPITATIONS 189 0.0016
328 MULTIPLE-DRUG RESISTANCE 5 0.0016
329 HYPERACUSIS 6 0.0016
330 MELANOCYTIC NAEVUS 7 0.0016
331 SPUTUM DISCOLOURED 15 0.0016
332 CEREBROVASCULAR ACCIDENT 266 0.0016
333 BRAIN NEOPLASM MALIGNANT 7 0.0016
334 HYPOALBUMINAEMIA 12 0.0015
335 SKIN NECROSIS 8 0.0015
336 C-REACTIVE PROTEIN INCREASED 56 0.0015
337 POOR QUALITY SLEEP 33 0.0015
338 EAR DISORDER 7 0.0015
339 INFUSION SITE HAEMORRHAGE 5 0.0015
340 UPPER RESPIRATORY TRACT INFECTION 70 0.0015
341 DRUG EXPOSURE DURING PREGNANCY 51 0.0015
342 BREAST MASS 10 0.0015
343 WOUND DEHISCENCE 5 0.0015
344 SKIN DISCOLOURATION 68 0.0015
345 PERIPHERAL VENOUS DISEASE 6 0.0015
346 THERAPY NON-RESPONDER 66 0.0015
347 ANAPHYLACTOID REACTION 6 0.0015
348 HYPERTENSIVE CRISIS 16 0.0014
349 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
350 CARDIAC FAILURE CHRONIC 6 0.0014
351 NASAL DISCOMFORT 11 0.0014
352 PHARYNGITIS STREPTOCOCCAL 15 0.0014
353 FINE MOTOR SKILL DYSFUNCTION 4 0.0014
354 ABSCESS 22 0.0014
355 GASTROINTESTINAL NECROSIS 4 0.0014
356 CUTANEOUS VASCULITIS 5 0.0014
357 PARONYCHIA 6 0.0014
358 WOUND 38 0.0014
359 LYMPHOMA 21 0.0014
360 POSTOPERATIVE WOUND INFECTION 9 0.0013
361 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
362 LUNG ADENOCARCINOMA 4 0.0013
363 HIV INFECTION 4 0.0013
364 MYELOFIBROSIS 4 0.0013
365 OSTEOPENIA 20 0.0013
366 CONFUSIONAL STATE 212 0.0013
367 SENSATION OF FOREIGN BODY 11 0.0013
368 RECTAL CANCER 4 0.0013
369 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
370 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
371 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
372 PANIC DISORDER 5 0.0013
373 THERAPEUTIC PRODUCT EFFECT DECREASED 57 0.0013
374 PROSTATOMEGALY 5 0.0013
375 INTESTINAL ISCHAEMIA 7 0.0013
376 COLITIS 48 0.0013
377 CARDIAC TAMPONADE 6 0.0013
378 PRODUCT PRESCRIBING ERROR 30 0.0013
379 NAIL DISORDER 11 0.0013
380 ACCIDENT 15 0.0013
381 BLEPHARITIS 5 0.0012
382 HEPATITIS C 15 0.0012
383 FINGER DEFORMITY 6 0.0012
384 DRUG INTOLERANCE 119 0.0012
385 RECURRENT CANCER 5 0.0012
386 LYMPHOCYTE COUNT INCREASED 4 0.0012
387 SKIN WARM 7 0.0012
388 DERMATITIS 25 0.0012
389 ARTERIOSCLEROSIS 11 0.0012
390 PRURITUS 449 0.0012
391 METASTATIC NEOPLASM 5 0.0012
392 AUTOIMMUNE HEPATITIS 8 0.0011
393 TONSILLITIS 6 0.0011
394 BURNING SENSATION 80 0.0011
395 GROIN PAIN 10 0.0011
396 GRIP STRENGTH DECREASED 10 0.0011
397 FURUNCLE 9 0.0011
398 IMMUNOSUPPRESSION 10 0.0011
399 LIMB DISCOMFORT 35 0.0011
400 SEASONAL ALLERGY 16 0.0011
401 MUSCULOSKELETAL STIFFNESS 99 0.0011
402 OBESITY 18 0.0011
403 FEAR OF INJECTION 8 0.0011
404 COUGH 314 0.0011
405 PNEUMONIA 361 0.0011
406 DYSURIA 41 0.0011
407 TYPE 2 DIABETES MELLITUS 37 0.0011
408 ISCHAEMIA 5 0.0011
409 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
410 EAR PAIN 21 0.0011
411 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
412 TEMPERATURE INTOLERANCE 11 0.0011
413 LIVER FUNCTION TEST ABNORMAL 31 0.0011
414 SKIN ABRASION 5 0.0011
415 CARDIAC FAILURE ACUTE 7 0.0010
416 SKIN MASS 7 0.0010
417 HEPATOTOXICITY 23 0.0010
418 RENAL DISORDER 48 0.0010
419 VASCULITIS 12 0.0010
420 ARTHROPATHY 57 0.0010
421 HEART RATE DECREASED 36 0.0010
422 NAIL DISCOLOURATION 4 0.0010
423 OSTEOARTHRITIS 43 0.0010
424 INFECTION 146 0.0010
425 PYREXIA 349 0.0010
426 SKIN ULCER 26 0.0010
427 OESOPHAGEAL CANDIDIASIS 4 0.0010
428 SYMPTOM RECURRENCE 6 0.0010
429 HEPATITIS B 6 0.0010
430 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
431 PULMONARY CONGESTION 13 0.0010
432 BLOOD POTASSIUM INCREASED 16 0.0010
433 SCOLIOSIS 6 0.0010
434 DERMATITIS BULLOUS 7 0.0010
435 DIARRHOEA HAEMORRHAGIC 9 0.0010
436 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 173 0.0010
437 HAEMATOCRIT DECREASED 19 0.0010
438 DIABETES MELLITUS 73 0.0010
439 UTERINE LEIOMYOMA 7 0.0010
440 DRY SKIN 127 0.0010
441 PULMONARY MASS 14 0.0009
442 POOR PERIPHERAL CIRCULATION 4 0.0009
443 SUNBURN 7 0.0009
444 FUNGAL INFECTION 31 0.0009
445 SKIN CANCER 20 0.0009
446 BLOOD IRON DECREASED 11 0.0009
447 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
448 LIVER DISORDER 41 0.0009
449 ERYTHEMA 190 0.0009
450 ANXIETY 263 0.0009
451 SKIN SWELLING 8 0.0009
452 BACK INJURY 10 0.0009
453 BOWEL MOVEMENT IRREGULARITY 7 0.0009
454 LIGAMENT SPRAIN 9 0.0009
455 BLISTER 51 0.0009
456 HYPERSOMNIA 26 0.0009
457 PHYSICAL DISABILITY 4 0.0009
458 DRUG INEFFECTIVE 1187 0.0009
459 INTRACRANIAL PRESSURE INCREASED 5 0.0009
460 MALIGNANT MELANOMA 12 0.0009
461 DRUG RESISTANCE 23 0.0009
462 QUALITY OF LIFE DECREASED 12 0.0009
463 EYE INFECTION 10 0.0009
464 NASAL CONGESTION 52 0.0009
465 TOOTH ABSCESS 9 0.0009
466 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
467 EXOSTOSIS 8 0.0009
468 THERAPEUTIC RESPONSE DECREASED 53 0.0009
469 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
470 NEOPLASM 10 0.0009
471 PERIPHERAL SWELLING 133 0.0009
472 CAESAREAN SECTION 10 0.0009
473 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 40 0.0009
474 DEFAECATION URGENCY 6 0.0009
475 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
476 IMPAIRED HEALING 28 0.0009
477 INCONTINENCE 9 0.0009
478 ABORTION INDUCED 8 0.0008
479 DIVERTICULUM 6 0.0008
480 CHRONIC LYMPHOCYTIC LEUKAEMIA 4 0.0008
481 HYPERLIPIDAEMIA 10 0.0008
482 TOOTH INFECTION 11 0.0008
483 TYPE 1 DIABETES MELLITUS 5 0.0008
484 HYPERTENSION 175 0.0008
485 BRONCHITIS 61 0.0008
486 RENAL CELL CARCINOMA 4 0.0008
487 FALL 272 0.0008
488 ORGANISING PNEUMONIA 4 0.0008
489 RESPIRATORY TRACT INFECTION 21 0.0008
490 OLIGURIA 5 0.0008
491 PAIN 493 0.0008
492 FISTULA 9 0.0008
493 BACK DISORDER 13 0.0008
494 NASAL DRYNESS 5 0.0008
495 SWELLING OF EYELID 5 0.0008
496 ERYSIPELAS 4 0.0008
497 DIVERTICULITIS 22 0.0008
498 MALAISE 348 0.0008
499 PHOTOPSIA 5 0.0008
500 MYOCARDIAL ISCHAEMIA 9 0.0008
501 HEPATOCELLULAR CARCINOMA 6 0.0008
502 DRY THROAT 8 0.0008
503 ENDOCARDITIS 4 0.0008
504 HAEMOLYSIS 6 0.0008
505 MADAROSIS 9 0.0008
506 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
507 ELECTROLYTE IMBALANCE 9 0.0008
508 RASH ERYTHEMATOUS 37 0.0008
509 LEUKOCYTOSIS 14 0.0008
510 RESTLESS LEGS SYNDROME 14 0.0008
511 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
512 PNEUMONIA BACTERIAL 7 0.0008
513 JOINT SWELLING 92 0.0008
514 RETINAL DETACHMENT 7 0.0008
515 BLOOD ALBUMIN DECREASED 6 0.0008
516 GASTROENTERITIS 11 0.0008
517 EAR INFECTION 20 0.0008
518 ANAL FISTULA 4 0.0007
519 HEPATIC ENZYME INCREASED 51 0.0007
520 HYPOGLYCAEMIA 36 0.0007
521 BURSITIS 9 0.0007
522 NO THERAPEUTIC RESPONSE 9 0.0007
523 DRUG ERUPTION 13 0.0007
524 WOUND INFECTION 8 0.0007
525 HAIR DISORDER 6 0.0007
526 WHEEZING 43 0.0007
527 THROMBOTIC MICROANGIOPATHY 7 0.0007
528 OSTEOMYELITIS 13 0.0007
529 ORAL HERPES 14 0.0007
530 MASS 10 0.0007
531 CONDITION AGGRAVATED 217 0.0007
532 GENERALISED ERYTHEMA 4 0.0007
533 NEUTROPHILIA 4 0.0007
534 RASH PRURITIC 38 0.0007
535 NEUTROPENIC SEPSIS 5 0.0007
536 IRRITABLE BOWEL SYNDROME 15 0.0007
537 INFLAMMATION 36 0.0007
538 CEREBRAL INFARCTION 17 0.0007
539 PRURITUS GENERALISED 15 0.0007
540 TONGUE DISORDER 5 0.0007
541 SEPSIS 77 0.0007
542 EYELID PTOSIS 7 0.0007
543 DRUG EFFECT INCOMPLETE 25 0.0007
544 LOCAL SWELLING 12 0.0007
545 PAIN IN EXTREMITY 200 0.0007
546 ACUTE MYOCARDIAL INFARCTION 20 0.0007
547 BLOOD PRESSURE DECREASED 45 0.0007
548 ASTHENIA 253 0.0007
549 OEDEMA 36 0.0007
550 THERAPEUTIC RESPONSE SHORTENED 22 0.0007
551 OSTEOPOROSIS 27 0.0007
552 ARTHRALGIA 272 0.0007
553 OVARIAN CANCER 6 0.0007
554 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
555 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
556 HYPERCALCAEMIA 8 0.0006
557 PIGMENTATION DISORDER 4 0.0006
558 MENSTRUATION DELAYED 7 0.0006
559 PHARYNGITIS 8 0.0006
560 SCAR 11 0.0006
561 OSTEONECROSIS 21 0.0006
562 LEUKAEMIA 6 0.0006
563 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
564 CONTUSION 61 0.0006
565 URTICARIA 106 0.0006
566 RECTAL HAEMORRHAGE 27 0.0006
567 FATIGUE 487 0.0006
568 VOMITING 294 0.0006
569 HEPATITIS 16 0.0006
570 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
571 OROPHARYNGEAL PAIN 57 0.0006
572 HEPATITIS ACUTE 4 0.0006
573 INJECTION SITE BRUISING 49 0.0006
574 INTERNAL HAEMORRHAGE 7 0.0006
575 DYSPEPSIA 60 0.0006
576 HYPERAESTHESIA 5 0.0006
577 TOOTHACHE 11 0.0006
578 EYELID OEDEMA 7 0.0006
579 HEADACHE 377 0.0006
580 NEOPLASM MALIGNANT 40 0.0006
581 JOINT RANGE OF MOTION DECREASED 8 0.0006
582 HYPOTHERMIA 6 0.0006
583 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
584 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
585 POLYNEUROPATHY 7 0.0006
586 BLOOD CREATININE INCREASED 38 0.0006
587 DRY EYE 29 0.0006
588 MYOPATHY 5 0.0006
589 GASTRIC ULCER 11 0.0006
590 PANCREATITIS ACUTE 13 0.0006
591 VENTRICULAR EXTRASYSTOLES 6 0.0006
592 LARGE INTESTINE POLYP 4 0.0006
593 PYELONEPHRITIS 5 0.0006
594 PRODUCT USE ISSUE 108 0.0006
595 HERPES ZOSTER 33 0.0006
596 SKIN BURNING SENSATION 41 0.0006
597 FOLLICULITIS 6 0.0006
598 SPINAL OSTEOARTHRITIS 5 0.0006
599 SKIN REACTION 8 0.0006
600 ULCER 9 0.0006
601 LYMPHADENOPATHY 20 0.0006
602 NAUSEA 447 0.0006
603 CYST 7 0.0006
604 HAIR COLOUR CHANGES 7 0.0006
605 JOINT INJURY 12 0.0006
606 DISCOMFORT 34 0.0006
607 PRODUCT USE IN UNAPPROVED INDICATION 138 0.0006
608 MOBILITY DECREASED 40 0.0006
609 OFF LABEL USE 484 0.0006
610 INJECTION SITE HAEMORRHAGE 44 0.0006
611 MAJOR DEPRESSION 4 0.0005
612 TOOTH FRACTURE 6 0.0005
613 PRODUCT ADMINISTRATION ERROR 11 0.0005
614 CARDIOMYOPATHY 8 0.0005
615 RASH MACULO-PAPULAR 12 0.0005
616 ABDOMINAL DISCOMFORT 90 0.0005
617 RASH PAPULAR 12 0.0005
618 LUNG NEOPLASM MALIGNANT 22 0.0005
619 KETOACIDOSIS 4 0.0005
620 DEPRESSED MOOD 28 0.0005
621 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
622 GASTRIC DISORDER 18 0.0005
623 ALOPECIA 102 0.0005
624 SINUS BRADYCARDIA 5 0.0005
625 BACK PAIN 120 0.0005
626 SPLENOMEGALY 6 0.0005
627 SPINAL PAIN 6 0.0005
628 LIP SWELLING 17 0.0005
629 RENAL CYST 4 0.0005
630 BLADDER DISORDER 5 0.0005
631 INABILITY TO AFFORD MEDICATION 5 0.0005
632 UPPER LIMB FRACTURE 10 0.0005
633 RENAL IMPAIRMENT 42 0.0005
634 BLOOD DISORDER 4 0.0005
635 BLOOD TEST ABNORMAL 7 0.0005
636 LYMPHOPENIA 7 0.0005
637 BODY TEMPERATURE INCREASED 10 0.0005
638 SUBDURAL HAEMATOMA 7 0.0005
639 LIVER INJURY 12 0.0005
640 DISEASE RECURRENCE 23 0.0005
641 NEPHROLITHIASIS 22 0.0005
642 DYSSTASIA 14 0.0005
643 LIMB INJURY 13 0.0005
644 ECZEMA 25 0.0005
645 ATRIAL SEPTAL DEFECT 4 0.0005
646 DIARRHOEA 308 0.0005
647 INFUSION SITE ERYTHEMA 4 0.0005
648 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
649 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
650 COLON CANCER 7 0.0005
651 FACIAL PARALYSIS 4 0.0005
652 THROAT IRRITATION 21 0.0005
653 HAEMATURIA 16 0.0005
654 INFUSION SITE PAIN 6 0.0005
655 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
656 SKIN LACERATION 5 0.0005
657 KIDNEY INFECTION 9 0.0005
658 MUCOSAL INFLAMMATION 12 0.0005
659 LUNG INFILTRATION 4 0.0005
660 PURPURA 4 0.0005
661 URINARY TRACT INFECTION 77 0.0005
662 NECK PAIN 25 0.0004
663 MYALGIA 76 0.0004
664 MALNUTRITION 5 0.0004
665 ILLNESS 46 0.0004
666 EMOTIONAL DISTRESS 54 0.0004
667 DYSPHONIA 26 0.0004
668 METASTASES TO LUNG 5 0.0004
669 CONJUNCTIVITIS 8 0.0004
670 CORONARY ARTERY DISEASE 13 0.0004
671 BACTERIAL INFECTION 8 0.0004
672 HEPATIC FUNCTION ABNORMAL 16 0.0004
673 PULMONARY OEDEMA 19 0.0004
674 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
675 NERVOUSNESS 22 0.0004
676 VIRAL INFECTION 14 0.0004
677 SYNCOPE 42 0.0004
678 JOINT STIFFNESS 11 0.0004
679 LIVER FUNCTION TEST INCREASED 9 0.0004
680 WRIST FRACTURE 5 0.0004
681 PULMONARY FIBROSIS 8 0.0004
682 PERICARDITIS 7 0.0004
683 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
684 MYELODYSPLASTIC SYNDROME 6 0.0004
685 ADRENAL INSUFFICIENCY 5 0.0004
686 HYPERGLYCAEMIA 15 0.0004
687 FIBROMYALGIA 10 0.0004
688 CIRCULATORY COLLAPSE 7 0.0004
689 METRORRHAGIA 7 0.0004
690 HAEMORRHOIDS 8 0.0004
691 JAUNDICE 11 0.0004
692 FREQUENT BOWEL MOVEMENTS 11 0.0004
693 HEPATOMEGALY 4 0.0004
694 SWELLING 38 0.0004
695 PEMPHIGUS 5 0.0004
696 DRUG INTERACTION 63 0.0004
697 FEELING COLD 11 0.0004
698 HAEMOPTYSIS 11 0.0004
699 WEIGHT DECREASED 110 0.0004
700 GAIT DISTURBANCE 75 0.0004
701 RENAL FAILURE 52 0.0004
702 NEUTROPHIL COUNT INCREASED 4 0.0004
703 LUNG INFECTION 6 0.0004
704 ANGIOEDEMA 17 0.0004
705 NODULE 5 0.0004
706 ACNE 29 0.0004
707 DRY MOUTH 31 0.0004
708 IMMUNE SYSTEM DISORDER 5 0.0004
709 PRODUCTIVE COUGH 18 0.0004
710 RASH 164 0.0004
711 COVID-19 66 0.0004
712 HOT FLUSH 28 0.0004
713 UVEITIS 5 0.0004
714 TACHYPNOEA 5 0.0004
715 LUNG DISORDER 18 0.0004
716 PRODUCT PRESCRIBING ISSUE 8 0.0004
717 PULMONARY THROMBOSIS 4 0.0004
718 SLEEP APNOEA SYNDROME 7 0.0004
719 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
720 METASTASES TO BONE 6 0.0004
721 LOWER LIMB FRACTURE 7 0.0004
722 PHOTOSENSITIVITY REACTION 6 0.0004
723 ASTHMA 41 0.0004
724 FOOT DEFORMITY 4 0.0004
725 HYPOMAGNESAEMIA 5 0.0004
726 CHOKING 7 0.0004
727 ORAL PAIN 8 0.0004
728 NEPHROPATHY TOXIC 4 0.0004
729 CARDIOVASCULAR DISORDER 9 0.0004
730 INTENTIONAL PRODUCT MISUSE 31 0.0004
731 BLOOD PRESSURE ABNORMAL 7 0.0004
732 DERMATITIS CONTACT 4 0.0004
733 ANAPHYLACTIC SHOCK 9 0.0003
734 MUSCULOSKELETAL DISCOMFORT 6 0.0003
735 IMPAIRED QUALITY OF LIFE 5 0.0003
736 HEAD INJURY 11 0.0003
737 TASTE DISORDER 7 0.0003
738 DEAFNESS 9 0.0003
739 BREAST CANCER 32 0.0003
740 BLOOD CHOLESTEROL INCREASED 16 0.0003
741 ATRIAL FIBRILLATION 33 0.0003
742 OEDEMA PERIPHERAL 41 0.0003
743 ISCHAEMIC STROKE 6 0.0003
744 THIRST 6 0.0003
745 IMMUNODEFICIENCY 5 0.0003
746 RESPIRATORY DISORDER 10 0.0003
747 BLOOD COUNT ABNORMAL 5 0.0003
748 SKIN IRRITATION 15 0.0003
749 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6 0.0003
750 DRUG ADMINISTRATION ERROR 10 0.0003
751 HAEMOGLOBIN DECREASED 33 0.0003
752 MYOCARDIAL INFARCTION 56 0.0003
753 BRADYCARDIA 17 0.0003
754 LEUKOPENIA 16 0.0003
755 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
756 HYPERHIDROSIS 41 0.0003
757 FLATULENCE 18 0.0003
758 STEVENS-JOHNSON SYNDROME 7 0.0003
759 HEPATIC CYTOLYSIS 4 0.0003
760 HYPOTHYROIDISM 10 0.0003
761 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
762 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
763 CARDIAC DISORDER 29 0.0003
764 RASH GENERALISED 8 0.0003
765 BONE PAIN 18 0.0003
766 DYSPNOEA 173 0.0003
767 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
768 MIGRAINE 29 0.0003
769 ANKYLOSING SPONDYLITIS 4 0.0003
770 PANCREATITIS 16 0.0003
771 CHILLS 35 0.0003
772 CHEST PAIN 55 0.0003
773 DISEASE PROGRESSION 35 0.0003
774 INCORRECT DOSE ADMINISTERED 67 0.0003
775 BLOOD PRESSURE FLUCTUATION 7 0.0003
776 NERVOUS SYSTEM DISORDER 9 0.0003
777 RASH MACULAR 10 0.0003
778 EOSINOPHILIA 5 0.0003
779 ENCEPHALOPATHY 7 0.0003
780 DEVICE OCCLUSION 4 0.0003
781 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
782 FEELING ABNORMAL 68 0.0003
783 HEAD DISCOMFORT 5 0.0003
784 EPISTAXIS 21 0.0003
785 MATERNAL EXPOSURE DURING PREGNANCY 25 0.0003
786 MOVEMENT DISORDER 9 0.0003
787 INSOMNIA 74 0.0003
788 FAECES DISCOLOURED 6 0.0003
789 HYPERTHYROIDISM 4 0.0003
790 HYPOKINESIA 4 0.0003
791 CHOLELITHIASIS 9 0.0003
792 RESPIRATORY FAILURE 20 0.0003
793 OCULAR HYPERAEMIA 13 0.0003
794 EYE DISORDER 9 0.0003
795 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
796 HAEMATOCHEZIA 15 0.0003
797 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
798 MUSCULOSKELETAL PAIN 14 0.0003
799 HYPOCALCAEMIA 5 0.0003
800 POLLAKIURIA 11 0.0003
801 BLOOD URINE PRESENT 5 0.0003
802 PLEURAL EFFUSION 16 0.0003
803 CARDIAC FAILURE CONGESTIVE 21 0.0003
804 DRUG PRESCRIBING ERROR 5 0.0003
805 ACUTE RESPIRATORY FAILURE 5 0.0003
806 ANKLE FRACTURE 4 0.0003
807 INJECTION SITE PAIN 79 0.0003
808 PNEUMONITIS 7 0.0003
809 RESPIRATORY DISTRESS 7 0.0003
810 ANAPHYLACTIC REACTION 14 0.0003
811 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
812 SEPTIC SHOCK 11 0.0003
813 DEPRESSION 57 0.0003
814 PANCYTOPENIA 14 0.0003
815 HEPATIC CANCER 6 0.0002
816 CARDIAC FAILURE 20 0.0002
817 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
818 PROSTATE CANCER 20 0.0002
819 ILL-DEFINED DISORDER 15 0.0002
820 DERMATITIS ATOPIC 13 0.0002
821 FEEDING DISORDER 5 0.0002
822 PRODUCT DOSE OMISSION 16 0.0002
823 ABDOMINAL PAIN 57 0.0002
824 FEELING HOT 15 0.0002
825 SUICIDAL IDEATION 22 0.0002
826 ROAD TRAFFIC ACCIDENT 10 0.0002
827 ABDOMINAL PAIN UPPER 49 0.0002
828 TREATMENT NONCOMPLIANCE 13 0.0002
829 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
830 THROMBOCYTOPENIA 26 0.0002
831 HEPATIC FAILURE 7 0.0002
832 RENAL CANCER 11 0.0002
833 PRODUCT DISPENSING ERROR 5 0.0002
834 METASTASES TO LIVER 4 0.0002
835 ANAEMIA 43 0.0002
836 COLITIS ULCERATIVE 10 0.0002
837 FEAR 6 0.0002
838 HEART RATE IRREGULAR 5 0.0002
839 PULMONARY EMBOLISM 21 0.0002
840 NEUTROPHIL COUNT DECREASED 9 0.0002
841 METABOLIC ACIDOSIS 7 0.0002
842 INJECTION SITE REACTION 15 0.0002
843 FLUID RETENTION 11 0.0002
844 VERTIGO 13 0.0002
845 INTENTIONAL DOSE OMISSION 6 0.0002
846 HAEMORRHAGE 22 0.0002
847 MUSCULOSKELETAL DISORDER 4 0.0002
848 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
849 CHOLESTASIS 4 0.0002
850 POST PROCEDURAL COMPLICATION 4 0.0002
851 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
852 HYPERSENSITIVITY 38 0.0002
853 ASCITES 6 0.0002
854 BLADDER CANCER 12 0.0002
855 URINARY INCONTINENCE 6 0.0002
856 ABASIA 5 0.0002
857 SWELLING FACE 13 0.0002
858 PREMATURE BABY 6 0.0002
859 LACRIMATION INCREASED 6 0.0002
860 ABDOMINAL PAIN LOWER 5 0.0002
861 BONE MARROW FAILURE 4 0.0002
862 PRODUCT STORAGE ERROR 17 0.0002
863 CRYING 7 0.0002
864 SWOLLEN TONGUE 6 0.0002
865 KNEE ARTHROPLASTY 4 0.0002
866 ADVERSE DRUG REACTION 17 0.0002
867 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
868 BLOOD BILIRUBIN INCREASED 5 0.0002
869 DEVICE MALFUNCTION 13 0.0002
870 CHRONIC KIDNEY DISEASE 14 0.0002
871 MENTAL DISORDER 8 0.0002
872 FEBRILE NEUTROPENIA 12 0.0002
873 VISUAL ACUITY REDUCED 6 0.0002
874 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
875 PRODUCT AVAILABILITY ISSUE 4 0.0002
876 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
877 DIZZINESS 86 0.0002
878 SPEECH DISORDER 9 0.0002
879 HYPOXIA 6 0.0002
880 DEEP VEIN THROMBOSIS 11 0.0002
881 TACHYCARDIA 15 0.0002
882 INFUSION RELATED REACTION 11 0.0002
883 INTERSTITIAL LUNG DISEASE 8 0.0002
884 STOMATITIS 10 0.0002
885 EPILEPSY 5 0.0002
886 ADVERSE EVENT 15 0.0002
887 VISUAL IMPAIRMENT 20 0.0002
888 WEIGHT INCREASED 36 0.0002
889 LETHARGY 9 0.0002
890 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
891 ERECTILE DYSFUNCTION 4 0.0002
892 DIPLOPIA 4 0.0002
893 GASTRITIS 4 0.0002
894 ACUTE KIDNEY INJURY 23 0.0002
895 BREAST CANCER FEMALE 4 0.0001
896 VISION BLURRED 20 0.0001
897 MEMORY IMPAIRMENT 20 0.0001
898 DEVICE ISSUE 13 0.0001
899 NIGHTMARE 5 0.0001
900 DEMENTIA 4 0.0001
901 RED BLOOD CELL COUNT DECREASED 4 0.0001
902 PARAESTHESIA 22 0.0001
903 HYPOTENSION 28 0.0001
904 HYPOACUSIS 6 0.0001
905 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
906 MYELOSUPPRESSION 5 0.0001
907 TREMOR 23 0.0001
908 PANCREATIC CARCINOMA 4 0.0001
909 THROMBOSIS 11 0.0001
910 THERAPY CESSATION 7 0.0001
911 LABORATORY TEST ABNORMAL 4 0.0001
912 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
913 HYPOAESTHESIA 20 0.0001
914 CONSTIPATION 29 0.0001
915 MUSCLE SPASMS 24 0.0001
916 TINNITUS 6 0.0001
917 INJECTION SITE SWELLING 10 0.0001
918 DISTURBANCE IN ATTENTION 7 0.0001
919 BALANCE DISORDER 11 0.0001
920 COMA 6 0.0001
921 THERAPY INTERRUPTED 9 0.0001
922 DECREASED APPETITE 29 0.0001
923 HIP FRACTURE 4 0.0001
924 AMNESIA 8 0.0001
925 INJECTION SITE ERYTHEMA 15 0.0001
926 PRODUCT DOSE OMISSION ISSUE 35 0.0001
927 ANGER 4 0.0001
928 RENAL FAILURE ACUTE 5 0.0001
929 DEATH 101 0.0001
930 ABDOMINAL DISTENSION 12 0.0001
931 INJURY 8 0.0001
932 SLEEP DISORDER 8 0.0001
933 CEREBRAL HAEMORRHAGE 4 0.0001
934 DRUG EFFECT DECREASED 6 0.0001
935 HEART RATE INCREASED 11 0.0001
936 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
937 PANIC ATTACK 4 0.0001
938 AGITATION 8 0.0001
939 HYPOKALAEMIA 5 0.0001
940 MEDICATION ERROR 6 0.0001
941 EYE PAIN 6 0.0001
942 DYSPNOEA EXERTIONAL 4 0.0001
943 INTESTINAL OBSTRUCTION 4 0.0001
944 ARRHYTHMIA 5 0.0001
945 SOMNOLENCE 21 0.0001
946 EYE IRRITATION 6 0.0001
947 BLOOD GLUCOSE DECREASED 5 0.0001
948 SURGERY 6 0.0001
949 DISORIENTATION 4 0.0001
950 ABORTION SPONTANEOUS 4 0.0001
951 IRRITABILITY 6 0.0001
952 DYSKINESIA 4 0.0001
953 BLINDNESS 4 0.0001
954 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
955 HOSPITALISATION 15 0.0001
956 DEHYDRATION 13 0.0001
957 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
958 NEUTROPENIA 12 0.0001
959 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
960 PLATELET COUNT DECREASED 9 0.0001
961 NEUROPATHY PERIPHERAL 8 0.0001
962 COLORECTAL CANCER 4 0.0001
963 SUICIDE ATTEMPT 5 0.0001
964 DRUG DEPENDENCE 13 0.0001
965 UNEVALUABLE EVENT 6 0.0001
966 HYPONATRAEMIA 4 0.0001
967 CONVULSION 4 0.0001
968 PRODUCT SUBSTITUTION ISSUE 4 0.0001
969 SEIZURE 8 0.0001
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
971 FLUSHING 7 0.0001
972 UNDERDOSE 5 0.0001
973 EXPOSURE DURING PREGNANCY 4 0.0001
974 BLOOD GLUCOSE INCREASED 12 0.0001
975 CARDIAC ARREST 5 0.0001
976 DEVICE DIFFICULT TO USE 4 0.0001
977 OVERDOSE 13 0.0001
978 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
979 DRUG WITHDRAWAL SYNDROME 5 0.0001
980 NO ADVERSE EVENT 10 0.0001
981 DRUG DOSE OMISSION 8 0.0000
982 DRUG ABUSE 4 0.0000
983 LOSS OF CONSCIOUSNESS 5 0.0000
984 TOXICITY TO VARIOUS AGENTS 6 0.0000